D. E. Shaw & Co., Inc. Geron Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Geron Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 31,991 shares of GERN stock, worth $93,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,991

Holding current value

$93,733

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $133,402 - $159,635	31,991 New	31,991 $145,000
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $2.61 Million - $4.89 Million	-1,324,777 Reduced 80.56%	319,611 $1.03 Million
Q1 2023 May 15, 2023	SELL	$2.14 - $3.4 $744,394 - $1.18 Million	-347,848 Reduced 17.46%	1,644,388 $3.57 Million
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $1.12 Million - $1.33 Million	-550,643 Reduced 21.65%	1,992,236 $4.82 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $2.78 Million - $4.89 Million	1,663,743 Added 189.25%	2,542,879 $5.95 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $794,056 - $1.1 Million	667,274 Added 314.96%	879,136 $1.36 Million
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $209,743 - $338,979	211,862 New	211,862 $288,000
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $133,095 - $194,851	-106,476 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $1.39 Million - $1.92 Million	-916,081 Reduced 89.59%	106,476 $168,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $1.05 Million - $1.39 Million	678,468 Added 197.18%	1,022,557 $1.63 Million
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $547,101 - $753,554	344,089 New	344,089 $599,000
Q3 2019 Nov 14, 2019	SELL	$1.15 - $1.59 $18,285 - $25,281	-15,900 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.37 - $2.02 $69,738 - $102,826	-50,904 Reduced 76.2%	15,900 $22,000
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $183,818 - $333,058	-181,999 Reduced 73.15%	66,804 $111,000
Q4 2018 Feb 14, 2019	BUY	$0.98 - $1.85 $225,230 - $425,179	229,827 Added 1211.15%	248,803 $249,000
Q3 2018 Nov 14, 2018	SELL	$1.76 - $6.38 $25,583 - $92,739	-14,536 Reduced 43.38%	18,976 $33,000
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $110,254 - $161,527	33,512 New	33,512 $115,000
Q1 2018 May 15, 2018	SELL	$1.81 - $5.98 $210,291 - $694,774	-116,183 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.8 - $2.32 $182,388 - $235,078	101,327 Added 682.06%	116,183 $209,000
Q3 2017 Nov 14, 2017	BUY	$1.99 - $2.65 $29,563 - $39,368	14,856	14,856 $32,000

Others Institutions Holding GERN

# of Institutions

281

Shares Held

492M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.11B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account